Although SP-B deficiency may predispose to lung injury, it is unclear whether increased levels of SP-B have a protecAlveolar stability at low lung volumes is maintained by the tive effect on lung function during injury. Pretreatment of formation and maintenance of a surfactant film at the air-SP-B(ϩ/Ϫ) mice with SP-B corrected the oxygen-induced liquid interface of the alveolus. A key component of the sursurfactant dysfunction (19). Exposure of wild-type mice to face film is dipalmitoylphosphatidylcholine, which reduces aerosolized endotoxin resulted in lung inflammation and surface tension to low levels at end-expiration, thereby decreased levels of SP-B coincident with surfactant dysfuncpreventing alveolar collapse. The formation and stability tion (17). Addition of a mixture of SP-B and SP-C to surfacof the surfactant phospholipid film is highly dependent upon tant isolated from endotoxin-exposed mice significantly imthe presence of specific hydrophobic peptides associated proved the surface properties of isolated surfactant in vitro with surfactant phospholipids, including surfactant protein (17). The present study was undertaken to assess whether (SP)-B and SP-C. Mutations in the human SP-B gene that genetically increased levels of SP-B would improve lung lead to the complete absence of SP-B protein are also associfunction and diminish lung inflammation following intratraated with aberrant processing of the SP-C proprotein and cheal endotoxin exposure. decreased levels of SP-C mature peptide in the alveolar airspaces (1). SP-B deficiency results in neonatal respiratory
Whether the decrease in SP-B protein concentration con- Although SP-B deficiency may predispose to lung injury, it is unclear whether increased levels of SP-B have a protecAlveolar stability at low lung volumes is maintained by the tive effect on lung function during injury. Pretreatment of formation and maintenance of a surfactant film at the air-SP-B(ϩ/Ϫ) mice with SP-B corrected the oxygen-induced liquid interface of the alveolus. A key component of the sursurfactant dysfunction (19) . Exposure of wild-type mice to face film is dipalmitoylphosphatidylcholine, which reduces aerosolized endotoxin resulted in lung inflammation and surface tension to low levels at end-expiration, thereby decreased levels of SP-B coincident with surfactant dysfuncpreventing alveolar collapse. The formation and stability tion (17). Addition of a mixture of SP-B and SP-C to surfacof the surfactant phospholipid film is highly dependent upon tant isolated from endotoxin-exposed mice significantly imthe presence of specific hydrophobic peptides associated proved the surface properties of isolated surfactant in vitro with surfactant phospholipids, including surfactant protein (17). The present study was undertaken to assess whether (SP)-B and SP-C. Mutations in the human SP-B gene that genetically increased levels of SP-B would improve lung lead to the complete absence of SP-B protein are also associfunction and diminish lung inflammation following intratraated with aberrant processing of the SP-C proprotein and cheal endotoxin exposure. decreased levels of SP-C mature peptide in the alveolar airspaces (1). SP-B deficiency results in neonatal respiratory
Materials and Methods

distress syndrome that is generally fatal despite intensive Mice
Three groups of mice were used for the current studies: SP-B heterozygous mice (SP-Bϩ/Ϫ), wild-type mice (SP-Bϩ/ϩ), and mice or SP-Bϩ/ϩ/ϩ). Generation of SP-B(ϩ/Ϫ) and SP-B(ϩ/ϩ/ϩ) growth, and reproductive capacity. All mice were housed under pathogen-free conditions and were studied under a protocol approved by the Institutional Animal Care and Use Committee. For each experiment, 5-to 6-wk-old (20-25 g body weight) littermates were used.
Endotoxin Treatment
Mice were anesthetized with isofluorane, and 0.5 g of Escherichia coli F583 (Sigma Chemical Co, St. Louis, MO), suspended in 100 l endotoxin-free phosphate-buffered saline (PBS), was administered intratracheally just below the corticoid cartilage. Untreated control mice and mice treated identically with an equal volume of vehicle Figure 1 . Levels of SP-B in BALF. Five-week-old SP-B(ϩ/ϩ), were also evaluated. At various time points after treatment, mice SP-B(ϩ/Ϫ), or SP-B(ϩ/ϩ/ϩ) mice were injected intratracheally were anesthetized with intraperitoneal pentobarbital, and the lungs with 0.5 g of endotoxin (n ϭ 5 for each time point). At 3, 6, 24, lavaged with three 1-ml aliquots of PBS. Aliquots of BALF con-48, and 72 h after injection, BALF was obtained from 4-5 mice, taining protease inhibitor cocktail (Sigma) were stored at Ϫ70ЊC
and SP-B levels measured by ELISA. Control groups included until analysis. For cell counts, an aliquot of BALF was centrifuged uninjected mice and mice injected with PBS. SP-B levels in injected at 250 ϫ g for 10 min, and the cell pellet washed in red blood cell controls were not significantly different from uninjected controls; lysis buffer (0.1 M, NH 4 Cl in 0.1 M Tris pH 7.6, 0.1 mM EDTA) and only the 24-h time point is shown for the PBS-injected control resuspended in PBS for quantitative analysis by hemocytometry.
group. *P Ͻ 0.001, **P Ͻ 0.01, relative to SP-B(ϩ/ϩ/ϩ) mice. Differential cell counts were made on cytospin preparations stained * t P Ͻ 0.02, relative to PBS-injected mice of same genotype. with May-Grü nwald Giemsa stain (Diff-Quik; Scientific Products, McGraw Park, IL). Protein concentration in BALF was determined by the bicinchoninic assay (22) . Aliquots of BALF containing 0.5 g protein were analyzed by Western blotting using antibodies diequilibrium surface tension, then bubble pulsation was started.
rected against SP-A (23), SP-D (24), or SP-C (25). The level of ma-
The minimum surface tension after 65% bubble volume reduction ture SP-B peptide in BALF was quantitated by enzyme-linked was measured at the fifth pulsation. immunosorbent assay (ELISA) (20) . Cytokine levels in BALF were measured by sandwich immunoassay (R&D Systems, MinneResults apolis, MN). All samples were assayed in duplicate. Differences between groups were assessed by one-way ANOVA, and differences SP-B(ϩ/ϩ) mice or SP-B(ϩ/Ϫ) mice. As an additional in-SP-C in BALF were similar in all groups of mice 6 h after intratracheal injection of endotoxin ( Figure 5 ). Nitrite levels dex of pulmonary inflammation, levels of selected cytokines in BALF were assessed 6 h after intratracheal injection of in BALF were also similar among the three groups of mice at 6 h after treatment, and were not significantly different endotoxin . Levels of inflam-0.5 g of endotoxin (n ϭ 5 for each group). Twenty-four hours after infection, BALF was collected for analysis of total and differmatory mediators in BALF from uninjected mice were below the detection limit. *P Ͻ 0.05 relative to SP-B(ϩ/ϩ) and SP-B(ϩ/ϩ/ϩ) ential cell counts. *P Ͻ 0.02, **P Ͻ 0.03 relative to SP-B(ϩ/Ϫ) mice.
Effect of Endotoxin on Alveolar SP-B Levels
mice. increase bacterial killing in SP-B(ϩ/ϩ/ϩ) mice, and dechange in tissue elastance was less than that in the other creased levels of SP-B in SP-B(ϩ/Ϫ) mice did not increase genotypes, with only a 1.4-fold increase. Lung mechanics were susceptibility to infection (20) ; however, the effect of SP-B altered by endotoxin in both SP-B(ϩ/ϩ) and SP-B(ϩ/Ϫ) levels on inflammation association with infection was not mice, whereas SP-B(ϩ/ϩ/ϩ) mice showed minimal changes assessed in these mice. In the present study, endotoxinin lung mechanics or no changes at all.
induced lung inflammation, assessed by influx of neutrophils Surfactant Function and elaboration of proinflammatory cytokines in the airspaces, was abrogated in mice expressing higher levels of The surface activities of large aggregate surfactant isolated SP-B peptide. Increased concentration of SP-B in BALF from BALF of unchallenged SP-B(ϩ/Ϫ), SP-B(ϩ/ϩ), and was also associated with significantly improved lung func-SP-B(ϩ/ϩ/ϩ) mice were compared using a captive bubble tion in endotoxin-challenged mice. Taken together, these surfactometer. Equilibrium surface tensions of surfactant results suggest that SP-B is not an antibacterial peptide, obtained from the three groups of mice were comparable (not shown). Minimum surface tension of surfactant was low for but may play an important role in protecting against lung all three groups, but was significantly lower in SP-B(ϩ/ϩ/ϩ) inflammation arising from bacterial infection. mice compared with SP-B(ϩ/Ϫ) and SP-B(ϩ/ϩ) mice. In It is not clear if the protective effect of SP-B is related the presence of 5% plasma protein, low surface tension to an anti-inflammatory property of the peptide. Miles and was maintained by surfactant from SP-B(ϩ/ϩ/ϩ) and coworkers (29) reported that SP-B inhibited endotoxin-SP-B(ϩ/ϩ) but not SP-B(ϩ/Ϫ) mice. Minimum surface teninduced nitric oxide production by isolated alveolar macrosion in the presence of 10% plasma protein was increased phages, consistent with a direct anti-inflammatory effect. for all three groups, but the increase was significantly lower However, in the present study, nitrite levels were similar for surfactant from SP-B(ϩ/ϩ/ϩ) mice, suggesting that surin SP-B(ϩ/Ϫ) and SP-B(ϩ/ϩ/ϩ) mice, suggesting that nifactant from these mice is more resistant to plasma protein tric oxide levels were not influenced by SP-B following treatmediated surfactant dysfunction (Figure 7) . ment with endotoxin. Elevated levels of mature SP-B peptide were, however, associated with enhanced surfactant Discussion function (lower minimum surface tension) and increased resistance of surfactant to inhibition by plasma proteins SP-B expression was genetically manipulated to generate in surfactant from unchallenged mice and lower levels of transgenic mouse lines in which SP-B concentrations in BALF protein in BALF following endotoxin challenge in vivo. varied without changing alveolar surfactant pool sizes or
The effect of endotoxin on lung function, as assessed by surfactant phospholipid composition (7, 21) . In a previous study, elevated concentration of SP-B in BALF did not compliance, tissue damping, and tissue elastance, was sig-least in the SP-B(ϩ/ϩ/ϩ) group. An inhibitory effect of endotoxin on SP-B expression has previously been reported. Exposure of 129J mice to aerosolized endotoxin resulted in decreased SP-B mRNA and mature peptide without significant change in SP-A levels (17). Intratracheal administration of endotoxin to FVB/N mice resulted in decreased staining of alveolar epithelial cells for SP-B and SP-C proproteins, although staining for SP-B mature peptide was increased in the airspaces (18) . In the present study, intratracheal administration of endotoxin to FVB/N mice resulted in decreased levels of mature SP-B peptide in BALF In the present study, TNF-␣ levels were highest in BALF anti-inflammatory effect of SP-B, they do suggest that SP-B of SP-B(ϩ/Ϫ) mice. The fact that this group also had the may indirectly protect against endotoxin-induced lung greatest decrease in mature SP-B peptide levels following inflammation by reducing the severity of lung injury in endotoxin exposure suggests that this cytokine may partly SP-B(ϩ/ϩ/ϩ) mice, resulting in decreased influx of inflamaccount for the increased susceptibility of SP-B(ϩ/Ϫ) mice matory cells.
to endotoxin-induced lung inflammation. It remains unclear An alternative explanation for decreased inflammation and if other cytokines secreted in response to endotoxin treatimproved lung function in endotoxin-treated SP-B(ϩ/ϩ/ϩ) ment contribute to this effect. mice is that SP-B directly or indirectly inhibits endotoxin In summary, elevated levels of mature SP-B peptide in action. Alveolar surfactant pool size and surfactant phosthe airspaces of transgenic mice were associated with depholipid composition were not significantly different among creased inflammation following exposure to endotoxin. The the SP-B(ϩ/Ϫ), SP-B(ϩ/ϩ), and SP-B(ϩ/ϩ/ϩ) groups, sugprotective effect of SP-B was likely mediated through engesting that quantitative or qualitative differences in surfachanced surfactant function, leading to reduced lung injury, tant phospholipids could not account for the diminished decreased influx of inflammatory cells, and lower cytokine effect of endotoxin in SP-B-overexpressing mice. Surfaclevels. Endotoxin treatment of SP-B(ϩ/Ϫ) mice resulted in tant proteins, including SP-A (30), SP-D (31), and SP-C decreased SP-B peptide levels, which likely exacerbated (32, 33), bind to endotoxin; however, the concentration of lung injury in this group. Collectively, these results suggest each of those surfactant proteins was not altered by overthat infection superimposed on SP-B deficiency leads to a or underexpression of SP-B ( Figure 5 ). It is unlikely that significantly worse outcome; in contrast, elevated levels of SP-B binds to endotoxin, because it was recently reported SP-B peptide, in the absence of increased surfactant phosthat SP-C was the only hydrophobic component of surfacpholipids or other surfactant proteins, inhibits endotoxintant that bound endotoxin. Given these results, it seems induced lung inflammation. likely that the protective effect of SP-B is mediated through enhanced surfactant function rather than inhibition of endo-
